A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP
Clinical trial NCT04066881 · COMPLETED
Trial details
- NCT number
- NCT04066881
- Sponsor
- MRC/UVRI and LSHTM Uganda Research Unit
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2024-12-31
- Enrollment
- 1512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.